Investor Sentiment Falls to Post-Election Low
Reliq Health (RHT: CA) Closes $762,304 Debenture Financing
Spotlighting Companies That are Really Making a Difference on Earth Day
Stocks Edged Higher Last Week As Earnings Season Begins
Bill O’Reilly Learns the Hard Way That Credibility Matters
Gerald Commissiong of Amarantus Bioscience gives Equities.com a comprehensive overview of his company and its roadmap.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).